|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Jun―28 |
Neoadjuvant T-DM1 for HER2-positive breast cancer used as a bridging strategy during COVID-19 pandemic: lessons learned-a case series |
Adrian Choppa, Fardeen Bhimani, Angela Foley, Sun Young Oh, Della Makower, Sheldon Feldman, et al. (+4) Kelly Johnson, Fernand Bteich, K. H. Ramesh, Maureen P. McEvoy |
2 |
[GO] |
2022―Sep―20 |
A web-based survey of SARS-CoV-2 vaccination and its adverse effects in Chinese postoperative patients with breast cancer: a cross-sectional study |
Xiaoxiao Wang, Minxue Shen, Qian Zhang, Xiaomin Wang, Hanghao Zhang, Tingxuan Li, et al. (+3) Yuanping Hu, Fan Xia, Liqiu Liao |
3 |
[GO] |
2021―Aug―19 |
Breakthrough in breast reconstruction in the context of COVID-19: safety and efficiency of endoscopic breast reconstruction at a day surgery center |
Jiao Zhou, Xinran Liu, Yu Feng, Juan Li, Xiangquan Qin, Yixuan Huang, et al. (+6) Huanzuo Yang, Mengxue Qiu, Yang Liu, Hongsheng Ma, Qing Lv, Zhenggui Du |
|